Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNapoli, Italy, 80131 was removed and Naples, Italy, 80131 was added in the locations list. The page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. This appears to be a minor update to the page or its documents without affecting trial data, eligibility, or results.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedNew UI/text elements include a glossary toggle, a 'Last Update Submitted that Met QC Criteria' label, and a 'No FEAR Act Data' notice, while the page revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of Revision: v3.3.3; this is a metadata update and does not affect study content or functionality.SummaryDifference0.0%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.